ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in ProPhase Labs, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q4 2021
- Shares held
- 1.54M
- +28.8K (+1.9%) vs. Q4 2021
- Total value
- $10.8M
- −$56.0K (−0.5%) vs. Q4 2021
- New holders
- 1
- 8 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $2 |
| Q1 2026 | 2 | $2 |
| Q4 2025 | 17 | $92.9K |
| Q3 2025 | 29 | $1.36M |
| Q2 2025 | 33 | $1.05M |
| Q1 2025 | 37 | $2.02M |
| Q4 2024 | 30 | $1.91M |
| Q3 2024 | 27 | $4.23M |
| Q2 2024 | 29 | $7.27M |
| Q1 2024 | 32 | $11.0M |
| Q4 2023 | 27 | $7.63M |
| Q3 2023 | 35 | $8.56M |
| Q2 2023 | 45 | $15.8M |
| Q1 2023 | 39 | $18.6M |
| Q4 2022 | 51 | $26.7M |
| Q3 2022 | 43 | $30.3M |
| Q2 2022 | 39 | $24.9M |
| Q1 2022 | 22 | $10.8M |
| Q4 2021 | 25 | $10.8M |
| Q3 2021 | 21 | $8.56M |
| Q2 2021 | 23 | $9.95M |
| Q1 2021 | 29 | $9.58M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding ProPhase Labs, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dixon Hughes Goodman Wealth Advisors LLC | 175 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,140 | $8.00K | 0.00% | +770+208.1% | Added |
| UBS Group AG | 1,504 | $11.0K | 0.00% | −364−19.5% | Reduced |
| Wells Fargo & Company | 1,608 | $12.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,888 | $20.0K | 0.00% | −3,339−53.6% | Reduced |
| Group One Trading, L.P. | 5,069 | $35.0K | 0.00% | +1,669+49.1% | Added |
| Susquehanna International Group, LLP | 11,434 | $80.0K | 0.00% | +11,434 | New |
| Citadel Advisors LLC | 17,926 | $125.0K | 0.00% | −10,523−37.0% | Reduced |
| Northern Trust Corp | 18,866 | $132.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 19,651 | $137.0K | 0.00% | +785+4.2% | Added |
| BlackRock Inc. | 25,820 | $180.0K | 0.00% | −889−3.3% | Reduced |
| Bank of America Corp | 29,350 | $205.0K | 0.00% | +750+2.6% | Added |
| State Street Corp | 31,063 | $217.0K | 0.00% | +3,868+14.2% | Added |
| Bank of New York Mellon Corp | 42,794 | $300.0K | 0.00% | −6,206−12.7% | Reduced |
| Geode Capital Management, LLC | 105,857 | $740.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 137,944 | $965.0K | 0.00% | +3,293+2.4% | Added |
| Avidian Wealth Solutions, LLC | 140,342 | $982.0K | 0.06% | +20,588+17.2% | Added |
| Perritt Capital Management Inc | 208,400 | $1.46M | 0.79% | −400−0.2% | Reduced |
| Renaissance Technologies LLC | 222,610 | $1.56M | 0.00% | −5,000−2.2% | Reduced |
| Vanguard Group Inc | 512,609 | $3.59M | 0.00% | +14,671+2.9% | Added |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,548−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |